Scientists who are deaf and hard of hearing (DHH) are underrepresented at all career stages, especially at the Ph.D. level. To address this, the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) training program for undergraduates who are deaf and hard of hearing at the Rochester Institute of Technology (RIT) in Rochester, New York, has committed to lifting barriers and increasing DHH representation in science.

Part of RIT’s National Technical Institute for the Deaf (NTID),
the program is now in its fifth year and prepares undergraduate students who are DHH to enter graduate programs through community-building activities, mentored research training, communication access services like interpretation, and much more. We’ve interviewed two RIT U-RISE students and its director to learn how the program supports its trainees.

“An important part of being in science is being in a community,” says Neil Garg, Ph.D., Distinguished Professor and chair of the department of chemistry and biochemistry at the University of California Los Angeles (UCLA). That philosophy has led him to prioritize mentorship, diversity, and inclusion—while maintaining research excellence—as well as re-envisioning what it means to educate students and the public.

Falling in Love With Chemistry

Science was always a part of Dr. Garg’s childhood. He participated in science fairs as a kid but says he did it for the community and not necessarily for the love of science. “When I look back on those projects, they were always with friends—never by myself,” he says. His parents were both scientists and strongly encouraged him to go into medicine, and although he became a premed major at New York University (NYU), he ultimately chose a different path.

“Being a researcher is special because there aren’t many jobs that allow you to spend the majority of your time thinking about the things you find the most interesting in the whole world,” says William Ratcliff, Ph.D., an associate professor of biological sciences and the director of the interdisciplinary graduate program in quantitative biosciences at Georgia Institute of Technology (Georgia Tech) in Atlanta. We talked with Dr. Ratcliff about his career path, research on yeast, and advice to budding scientists.

Q: How did you first become interested in science?

A: My family owns land in Northern California that has been passed down for more than 100 years. When I was a child, my brother and I would spend summers on that land getting lost in the woods. We would really see the forest for its parts: seeing how organisms interacted with one other, tracking stages of development, and listening to birdcalls. My grandmother would identify plants by their scientific names, and we’d discuss their reproduction strategies. We became amateur natural historians during those summers. Perhaps it’s no surprise my brother and I both got Ph.Ds. in biology.

Mentoring is a vital part of training the next generation of scientists.

“I have a hard time envisioning a career more exciting than science. It’s really magical to see an experimental result and, for a moment, be the only person in the universe to know something about the world,” says Markita Landry, Ph.D., an associate professor of chemical and biomolecular engineering at the University of California, Berkeley. In an interview, Dr. Landry shares with us her scientific journey, research with nanoparticles, and interests outside of the lab.

Q: What sparked your interest in science?

A: I was indirectly exposed to science growing up because my mom was in computer science, but I think moving to the United States is what made me very interested in it. My mother is Bolivian; my father is French-Canadian; and I grew up mostly in Quebec, Canada. When I was halfway through high school, we moved to the United States, and, for the first time, my classes were taught in English. I really gravitated to math and science because they made sense regardless of the language they were taught in.

Since its creation in 1962, NIGMS has supported the work of the recipients of 94 Nobel Prizes—44 in physiology or medicine and 50 in chemistry. NIGMS-funded investigators perform cutting-edge basic research that is foundational to understanding normal life processes and disease. Such important breakthroughs in chemistry and biology often fuel more focused research that, years later, leads to important medical advances or products such as medicines or biotechnology tools.

The most recent NIGMS-supported Nobel laureates are Carolyn R. Bertozzi, Ph.D., the Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences at Stanford University in Stanford, California, and K. Barry Sharpless, Ph.D., the W.M. Keck Professor of Chemistry at the Scripps Research Institute in La Jolla, California. They, along with Morten Meldal, Ph.D., a professor of chemistry at the University of Copenhagen in Denmark, are being recognized with the 2022 Nobel Prize in chemistry for their work on a transformative scientific approach known as “click chemistry.” The three scientists will receive their awards during a ceremony in Stockholm, Sweden, on December 10, 2022.

“Being able to ground your research in questions coming directly from your patients and their families is so meaningful and a huge part of why I’m interested in becoming a clinician-scientist,” says Amelia Wilhelm, an M.D.-Ph.D. student in the NIGMS-supported Medical Scientist Training Program (MSTP) at the University of Washington in Seattle. MSTPs prepare students to combine clinical practice and rigorous scientific research in their future careers.

Continuing the Family Tradition in Science

As a child of two scientists, Amelia was exposed to research and medical careers from an early age. She earned a bachelor’s degree in chemistry at Bates College in Lewiston, Maine, and then began working as a lab technician at the Children’s Hospital of Philadelphia in Pennsylvania. Watching the principal investigator of her lab, clinician-scientist Lindsey A. George, M.D., interact with patients inspired Amelia to pursue a similar career.